KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

GoodRx Holdings (GDRX) Depreciation & Amortization (IS) (2019 - 2025)

GoodRx Holdings' Depreciation & Amortization (IS) history spans 7 years, with the latest figure at $23.1 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 21.21% year-over-year to $23.1 million; the TTM value through Dec 2025 reached $85.2 million, up 22.55%, while the annual FY2025 figure was $85.2 million, 22.55% up from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $23.1 million at GoodRx Holdings, up from $21.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $43.6 million in Q4 2023 and bottomed at $5.4 million in Q1 2021.
  • The 5-year median for Depreciation & Amortization (IS) is $16.0 million (2023), against an average of $17.6 million.
  • The largest annual shift saw Depreciation & Amortization (IS) skyrocketed 180.74% in 2023 before it tumbled 56.21% in 2024.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $10.6 million in 2021, then skyrocketed by 45.88% to $15.5 million in 2022, then surged by 180.74% to $43.6 million in 2023, then crashed by 56.21% to $19.1 million in 2024, then grew by 21.21% to $23.1 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Depreciation & Amortization (IS) are $23.1 million (Q4 2025), $21.4 million (Q3 2025), and $19.7 million (Q2 2025).